Brian J. Malkin

Subscribe to Brian J. Malkin's Posts
Brian Malkin counsels pharmaceutical and biologic clients on Food and Drug Administration (FDA) regulatory matters and intellectual property (IP) law, with an emphasis on patent litigation. His practice at the intersection of FDA- regulated products and patent law makes him a valuable partner to drug manufacturers, biotechnology clients, medical device companies and cannabis companies as they develop new products and protect their innovations though life cycle management, bring their products to market and pursue transactional opportunities. Read Brian Malkin's full bio.

New Patent Eligibility Bill May Impact What Subject Matter Is Patentable


By on Aug 18, 2022
Posted In Uncategorized

On August 2, 2022, Senator Thom Tillis (R-NC) introduced the Patent Eligibility Restoration Act of 2022. Senator Tillis’s bill addresses patent subject matter eligibility by modifying 35 U.S.C. § 101 to mitigate areas in which it has been considered problematic in view of recent judicial decisions/exceptions construing it while retaining its core features. For some in...

Continue Reading



BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES